Sesha Neervannan PhD

Dr Sesha Neervannan is currently Senior Vice President of Pharmaceutical Development at Allergan. In his current role, he oversees Drug Product Development and Drug Delivery for both Small Molecules and Biologics, across all Therapeutic Areas from Late Discovery until Commercialization. Prior to joining Allergan, Sesha held senior positions at Bristol-Myers Squibb and Amgen. Over the last few years, he oversaw and contributed to several global product filings and approvals (Ozurdex™, Latisse™, Acuvail™, Lumigan 0.01%™, Zymaxid™, Trivaris™, Aczone® Gel 7.5%) as well as development, validation and launch of several OTC artificial tears products.

Dr Neervannan has several research publications and patents and is a well recognized invited speaker and serves on many Advisory Boards. He received his PhD in Pharmaceutical Chemistry at The University of Kansas.